Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

14.75
-0.0310-0.21%
Pre-market: 13.65-1.1000-7.46%08:16 EST
Volume:7.96M
Turnover:123.59M
Market Cap:228.85M
PE:- -
High:15.93
Open:14.58
Low:13.06
Close:14.78
52wk High:15.93
52wk Low:13.06
Shares:15.52M
Float Shares:11.14M
Volume Ratio:1.25
T/O Rate:71.52%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-4.9715
ROE:-43.98%
ROA:-26.47%
PB:0.14
PE(LYR):-2.97

Loading ...

Chardan Downgrades Avidity Biosciences to Neutral From Buy

MT Newswires Live
·
Nov 07, 2025

Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia

GlobeNewswire
·
Nov 06, 2025

ProQR Announces Third Quarter 2025 Operating and Financial Results

GlobeNewswire
·
Nov 06, 2025

Stoke Therapeutics Advances in RNA Medicine and Financial Growth

TIPRANKS
·
Nov 05, 2025

Wave Life Sciences Third Quarter 2025 Financial Results Scheduled for November 10, 2025

GlobeNewswire
·
Nov 04, 2025

Dexerials, Veritas In Silico to Develop High-Speed RNA Structure Analysis Technology

MT Newswires Live
·
Nov 04, 2025

Veritas In Silico and Dexerials Collaborate on Advanced RNA Measurement Technology

TIPRANKS
·
Nov 04, 2025

Is Avidity Biosciences Still Attractive After FDA Clearance and 42% Weekly Price Surge?

Simply Wall St.
·
Nov 01, 2025

Assessing Avidity Biosciences (RNA) Valuation Following Its Recent Share Price Rally

Simply Wall St.
·
Oct 30, 2025

Wave Life Sciences Announced Positive Target Engagement Data from INLIGHT Clinical Trial of WVE-007 for Obesity During Annual Research Day

GlobeNewswire
·
Oct 30, 2025

TD Cowen Downgrades Avidity Biosciences to Hold From Buy, Adjusts Price Target to $74 From $78

MT Newswires Live
·
Oct 29, 2025

U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft

Reuters
·
Oct 29, 2025

Avidity Biosciences downgraded to Hold from Buy at TD Cowen

TIPRANKS
·
Oct 29, 2025

Press Release: Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 10, 2025

Dow Jones
·
Oct 29, 2025

Wells Fargo Reaffirms Their Buy Rating on Avidity Biosciences (RNA)

TIPRANKS
·
Oct 29, 2025

Avidity Biosciences Cut to Neutral From Buy by Chardan Capital

Dow Jones
·
Oct 28, 2025

Avidity Biosciences Inc : Citigroup Cuts to Neutral From Buy

THOMSON REUTERS
·
Oct 28, 2025

'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours

Benzinga_recent_news
·
Oct 28, 2025

Stocks to Watch Tuesday: Amazon, NextEra, UnitedHealth, Nvidia -- WSJ

Dow Jones
·
Oct 28, 2025

U.S. RESEARCH ROUNDUP- BCB Bancorp, Cadence Design Systems, Intellia Therapeutics

Reuters
·
Oct 28, 2025